Table of Content


Introduction
Multiple Myeloma (Kahler Disease) - Overview
Multiple Myeloma (Kahler Disease) - Therapeutics Development
Multiple Myeloma (Kahler Disease) - Therapeutics Assessment
Multiple Myeloma (Kahler Disease) - Companies Involved in Therapeutics Development
Multiple Myeloma (Kahler Disease) - Drug Profiles
Multiple Myeloma (Kahler Disease) - Dormant Projects
Multiple Myeloma (Kahler Disease) - Discontinued Products
Multiple Myeloma (Kahler Disease) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Multiple Myeloma (Kahler Disease), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables


Number of Products under Development for Multiple Myeloma (Kahler Disease), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by 4SC AG, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Aadi Bioscience Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by AbbVie Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by ABL Bio Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Acepodia Biotech Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Actinium Pharmaceuticals Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Active Biotech AB, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Adicet Bio Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Aduro BioTech Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Aeglea BioTherapeutics Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Affimed GmbH, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Agenus Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Allife Medical Science and Technology Co Ltd, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Allogene Therapeutics Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Ambrx Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Amgen Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Anhui Anke Biotechnology (Group) Co Ltd, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Antengene Corp, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by APIM Therapeutics AS, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by APO-T BV, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Arcellx Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Molecular Templates Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by MolMed SpA, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Momenta Pharmaceuticals Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by MorphoSys AG, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Multitude therapeutics Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Mustang Bio Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Sorrento Therapeutics Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by SpecificiT Pharma Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Spectrum Pharmaceuticals Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Sphaera Pharma Pte Ltd, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by SpringWorks Therapeutics Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Starton Therapeutics Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Sunomix Therapeutics, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Surface Oncology Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Sutro Biopharma Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Suzhou Maximum Bio-tech Co Ltd, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by T-CURX GmbH, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by T-Knife GmbH, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by TaiGen Biotechnology Co Ltd, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Taiho Oncology Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by TaiRx Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Takeda Pharmaceutical Co Ltd, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Targazyme Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by TeneoBio Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Tiziana Life Sciences Plc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Tmunity Therapeutics Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Tolero Pharmaceuticals Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Transgene Biotek Ltd, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Trillium Therapeutics Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Triterpenoid Therapeutics Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Ube Industries Ltd, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Vaccibody AS, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Vaxil Bio Therapeutics Ltd, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Vichem Chemie Research Ltd, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Visterra Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Vycellix Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Vyriad Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by WindMIL Therapeutics Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Wugen Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Wuhan Bio-Raid Biotechnology Co Ltd, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Wuhan YZY Biopharma Co Ltd, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by XEME BioPharma Inc, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Xiangxue Life Sciences, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by XNK Therapeutics AB, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Zhengda Tianqing Pharmaceutical Group Co Ltd, H1 2020
Multiple Myeloma (Kahler Disease) - Pipeline by Zovis Pharmaceuticals, H1 2020
Multiple Myeloma (Kahler Disease) - Dormant Projects, H1 2020
Multiple Myeloma (Kahler Disease) - Discontinued Products, H1 2020